Hawryluk P. Kent insider trades
Hawryluk P. Kent has filed 9 Form 4s with the SEC that we hold, all for MBX Biosciences, Inc. (MBX), as President & CEO, Director. Across all of them we count 3 purchases worth $1.3M and 1 sale worth $17.9K reported on Form 4. In the last 12 months: 2 purchases ($798.4K) and 1 sale ($17.9K). The largest single trade was a purchase of 50,000 shares of MBX Biosciences, Inc. worth $534.5K, dated 2025-02-04. The first filing on our record is dated 2024-09-13 and the latest 2026-05-08.
MBX Biosciences, Inc. (MBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-04 | P, purchase reported on Form 4 | 50,000 | $534.5K | 2025-02-05 |
| 2025-10-20 | P, purchase reported on Form 4 | 20,000 | $272.8K | 2025-10-21 |
| 2026-03-13 | P, purchase reported on Form 4 | 18,500 | $525.6K | 2026-03-16 |
| 2026-05-06 | S, sale reported on Form 4 | 607 | $17.9K | 2026-05-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1673991) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms